ARMK Form 4: Director Kevin Wills Acquires 29.129 Dividend-Equivalent Shares

Kevin Wills, a director of Aramark (ARMK), reported a Form 4 filing showing an internal award-related acquisition dated 08/20/2025.

Rhea-AI Filing Summary

Kevin Wills, a director of Aramark (ARMK), reported a Form 4 filing showing an internal award-related acquisition dated 08/20/2025. The filing states 29.129 shares were acquired at $0 as dividend equivalent rights that accrued on deferred stock units held by the reporting person. After the reported transaction the filing shows the reporting person beneficially owning 16,696.312 shares. The filing explains these dividend equivalent rights vest on the same schedule as the underlying awards and were reported by an attorney-in-fact on 08/21/2025.

Positive

• Disclosure compliance: The reporting person timely filed a Form 4 and disclosed the acquisition of dividend equivalent rights.
• Non-cash award accrual: The acquisition reflects compensation alignment with shareholders through dividend-equivalent units that vest with underlying awards.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine insider acquisition of dividend equivalent rights; non-cash, vesting-linked awards.

The Form 4 discloses a small non-cash acquisition tied to deferred stock units rather than an open-market purchase. Such entries reflect compensation mechanics and dividend-equivalent accruals that vest with underlying awards and do not indicate a change in control or an immediate liquidity event. For governance review, the transaction is consistent with standard director compensation practices and requires monitoring only if aggregate insider activity or vesting schedules suggest concentrated timing.

Securities Analyst

TL;DR: Minor insider share increase from dividend equivalents; immaterial to overall ownership.

The reported 29.129 shares acquired at $0 increased reported beneficial ownership to 16,696.312 shares. This appears to be an incremental, plan-driven accrual rather than a market signal. From a securities perspective the disclosure fulfills Section 16 reporting obligations; the sizes shown are small relative to typical outstanding share counts and are unlikely to materially affect valuation or control considerations.

Insider Trade Summary

Grant/Award: 29.129 shares

Grant/Award 1 txn

Insider Wills Kevin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29.129	$0.00	$0.00

Holdings After Transaction: Common Stock — 16,696.312 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Kevin Wills (ARMK) report on Form 4 dated 08/20/2025?

The Form 4 reports that Kevin Wills acquired 29.129 shares as dividend equivalent rights at a price of $0, increasing beneficial ownership to 16,696.312 shares.

Why were the shares reported as acquired at $0 in the ARMK Form 4?

The filing states these were dividend equivalent rights accrued on deferred stock units, which are non-cash awards and therefore reported with a $0 purchase price.

When did the reported transaction for ARMK occur?

The transaction date shown on the Form 4 is 08/20/2025 and the Form was signed via attorney-in-fact on 08/21/2025.

How does the Form 4 describe vesting of these rights?

The Form 4 explains the dividend equivalent rights vest on the same schedules as the underlying awards held by the reporting person.

Does the Form 4 indicate a change in control or sale activity for ARMK insider holdings?

No. The filing shows an acquisition of dividend equivalent rights tied to deferred awards; it does not disclose any sale or change in control.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/21/2025 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wills Kevin

(Last) (First) (Middle)

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		A		29.129(1)	A	$0	16,696.312	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.